| Name | Designation | Appointment Date | Status | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hariharan Ramesh
Appointed as Director since March 2017 |
Director | 02-Mar-2017 | Current | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Pichai Chandrasekaran
Appointed as Managing Director since November 2011 |
Managing Director | 01-Nov-2011 | Current | ||||||||||||||||||||||||||||
|
Shanmugam Santhosh
Appointed as Director since November 2011 |
Director | 01-Nov-2011 | Current | ||||||||||||||||||||||||||||
|
Ariyalur Suryanarayanan Ramasamy
Appointed as Director since September 2016 |
Director | 24-Sep-2016 | Current | ||||||||||||||||||||||||||||
People Timeline
Explore the timeline of key personnel in Gladstone Pharma India Private Limited's leadership journey.
Loading...
Contact Details
- Address Plot No.274, Flat D, Pearl Flat, Nateshnagar, 2Nd Cross Street, Virugambakkam, Chennai Tamil Nadu, 600092, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 600092
- Country India
- Website gladstonepharma.com
Frequently Asked Questions
How can I contact Gladstone Pharma India Private Limited?
You can contact Gladstone Pharma India Private Limited through their registered address at Plot No.274, Flat D, Pearl Flat, Nateshnagar, 2Nd Cross Street, Virugambakkam, Chennai Tamil Nadu, 600092, India, or via their website at gladstonepharma.com. Social media links are also provided where applicable.
Who are the current directors of Gladstone Pharma India Private Limited?
The current directors of Gladstone Pharma India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- HARIHARAN RAMESH
- PICHAI CHANDRASEKARAN
- SHANMUGAM SANTHOSH
- ARIYALUR SURYANARAYANAN RAMASAMY
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.